| Dr Lynne Masako Yonemura, PHARMD | |
|
2233 Lomita Blvd, Lomita, CA 90717-1401 | |
| (310) 530-2444 | |
| (310) 530-8761 |
| Full Name | Dr Lynne Masako Yonemura |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2233 Lomita Blvd, Lomita, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922186477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH29138 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynne Masako Yonemura, PHARMD 2233 Lomita Blvd, Lomita, CA 90717-1401 Ph: (310) 530-2444 | Dr Lynne Masako Yonemura, PHARMD 2233 Lomita Blvd, Lomita, CA 90717-1401 Ph: (310) 530-2444 |
News Archive
University of Manchester scientists have discovered for the first time an important new way in which the human papilloma virus (HPV) triggers cancer in what could lead to new treatments for cervical and mouth cancer.
New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus.
An international panel has designed new guidelines to standardize how scientists report research that involves forecasting and prediction of how epidemics of infectious diseases unfold. Simon Pollett of the Walter Reed Army Institute of Research in Maryland, United States, and colleagues present the guidelines, called EPIFORGE, in the open-access journal PLOS Medicine on October 19th.
The University of Alabama at Birmingham has a number of presentations and experts available to comment on news being presented at the annual American College of Cardiology Scientific Sessions that begin Saturday, March 23, 2012, in Chicago.
Eli Lilly and Company announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
› Verified 2 days ago
Leslie Nicole Bohner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1852 Lomita Blvd, Suite 204, Lomita, CA 90717 Phone: 310-539-1750 Fax: 310-539-1734 | |
Mai Mina Than, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25829 Narbonne Ave, Lomita, CA 90717 Phone: 310-517-8520 | |
Michele Nelson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25829 Narbonne Ave, Lomita, CA 90717 Phone: 310-517-8520 | |
Audrey Fung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Pacific Coast Hwy, Lomita, CA 90717 Phone: 310-517-9535 | |
Eileen Trinh, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Pacific Coast Hwy, Lomita, CA 90717 Phone: 310-517-9535 Fax: 310-517-9552 | |
Mr. Kris Akira Nakasu Ii, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 Lomita Blvd, Lomita, CA 90717 Phone: 310-530-2444 Fax: 310-530-8761 | |
Dr. Amir Khan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25829 Narbonne Ave, Lomita, CA 90717 Phone: 310-517-8520 |